Vivo Capital, LLC Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$2.3T
Holdings
59
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (59 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | TILInstil Bio Inc | 12,486,787 | $241.2B | 10.44% | |
| 2 | ALXOALX Oncology Holdings Inc | 4,220,048 | $230.8B | 9.99% | |
| 3 | ASNDAscendis Pharma A/S | 1,526,359 | $200.8B | 8.69% | |
| 4 | AMRSEURAmyris, Inc | 11,639,929 | $190.5B | 8.25% | |
| 5 | —New Frontier Health Corp | 14,300,000 | $159.7B | 6.91% | |
| 6 | HRMYHarmony Biosciences Holdings Inc | 4,534,341 | $128.0B | 5.54% | |
| 7 | —Genetron Holdings Ltd | 6,339,860 | $127.7B | 5.53% | |
| 8 | TARSTarsus Pharmaceuticals Inc | 2,987,331 | $86.6B | 3.75% | |
| 9 | ALGSAligos Therapeutics Inc | 3,547,030 | $72.3B | 3.13% | |
| 10 | BOLT1EURBolt Therapeutics Inc | 3,871,291 | $59.9B | 2.59% | |
| 11 | KALVKalVista Pharmaceuticals Inc. | 1,863,296 | $44.6B | 1.93% | |
| 12 | EPIEUREssa Pharma Inc | 1,551,680 | $44.3B | 1.92% | |
| 13 | LEGNLegend Biotech Corp Sponsored | 956,702 | $39.3B | 1.70% | |
| 14 | SVASinovac Biotech Ltd. | 5,900,000 | $38.2B | 1.65% | |
| 15 | OPHTEURIveric Bio Inc | 5,966,527 | $37.6B | 1.63% | |
| 16 | —Sierra Oncology, Inc | 1,917,074 | $37.3B | 1.62% | |
| 17 | OLMAOlema Pharmaceuticals Inc | 1,238,575 | $34.7B | 1.50% | |
| 18 | CRNXCrinetics Pharmaceuticals Inc | 1,752,346 | $33.0B | 1.43% | |
| 19 | TERNTerns Pharmaceuticals Inc | 2,675,133 | $32.8B | 1.42% | |
| 20 | TCE2Celldex Therapeutics Inc | 968,906 | $32.4B | 1.40% | |
| 21 | ZLABZai Lab Ltd ADR | 175,000 | $31.0B | 1.34% | |
| 22 | —Impel NeuroPharma Inc | 2,884,789 | $25.5B | 1.11% | |
| 23 | ACRSAclaris Therapeutics, Inc. | 1,374,279 | $24.1B | 1.04% | |
| 24 | —Kadmon Holdings Inc | 5,817,459 | $22.5B | 0.97% | |
| 25 | VRNAVerona Pharma PLC ADR | 3,048,507 | $19.9B | 0.86% | |
| 26 | AVDLAvadel Pharmaceuticals PLC | 2,937,093 | $19.8B | 0.86% | |
| 27 | NVV1Novavax Inc | 88,046 | $18.7B | 0.81% | |
| 28 | GRCLGracell Biotechnologies Inc | 1,328,257 | $17.3B | 0.75% | |
| 29 | NKTXNkarta Inc | 512,225 | $16.2B | 0.70% | |
| 30 | CLDNEUREiger BioPharmaceuticals Inc | 1,791,257 | $15.3B | 0.66% | |
| 31 | CYTKCytokinetics Inc | 700,000 | $13.9B | 0.60% | |
| 32 | MREOMereo Biopharma Group PLC | 4,220,938 | $13.4B | 0.58% | |
| 33 | —Curis Inc | 1,553,500 | $12.5B | 0.54% | |
| 34 | 290AChinook Therapeutics Inc | 872,151 | $12.3B | 0.53% | |
| 35 | DYNDyne Therapeutics Inc | 577,642 | $12.2B | 0.53% | |
| 36 | ARQTArcutis Biotherapeutics Inc | 433,585 | $11.8B | 0.51% | |
| 37 | ARWRArrowhead Pharmaceuticals Inc | 137,411 | $11.4B | 0.49% | |
| 38 | KURAKura Oncology Inc | 525,262 | $11.0B | 0.47% | |
| 39 | DSGNDesign Therapeutics | 530,991 | $10.6B | 0.46% | |
| 40 | VALNValneva SE | 400,000 | $10.5B | 0.46% | |
| 41 | —Zymeworks Inc | 286,064 | $9.9B | 0.43% | |
| 42 | —Aslan Pharmaceuticals Ltd | 2,840,909 | $9.4B | 0.41% | |
| 43 | MRUSMerus NV | 442,000 | $9.3B | 0.40% | |
| 44 | CDXSCodexis, Inc | 388,144 | $8.8B | 0.38% | |
| 45 | —Satsuma Pharmaceuticals Inc | 1,232,394 | $8.7B | 0.38% | |
| 46 | PASGPassage Bio Inc | 646,001 | $8.6B | 0.37% | |
| 47 | LRMRLarimar Therapeutics Inc | 799,662 | $7.9B | 0.34% | |
| 48 | —Elevation Oncology Inc | 496,843 | $6.7B | 0.29% | |
| 49 | AUPHAurinia Pharmaceuticals Inc. | 500,732 | $6.5B | 0.28% | |
| 50 | FIXXEURHomology Medicines, Inc. | 853,143 | $6.2B | 0.27% | |
| 51 | ORTXUSDOrchard Therapeutics plc | 1,325,736 | $5.8B | 0.25% | |
| 52 | IMVTImmunovant Inc | 532,847 | $5.6B | 0.24% | |
| 53 | SNDXSyndax Pharmaceuticals Inc | 320,000 | $5.5B | 0.24% | |
| 54 | TXG10X Genomics Inc | 14,798 | $2.9B | 0.13% | |
| 55 | —Calliditas Therapeutics ADR | 62,306 | $1.8B | 0.08% | |
| 56 | —Zogenix Inc | 105,000 | $1.8B | 0.08% | |
| 57 | DTILPrecision Biosciences Inc | 140,255 | $1.8B | 0.08% | |
| 58 | 1T7Tricida, Inc. | 174,763 | $755.0M | 0.03% | |
| 59 | —Metacrine Inc | 146,426 | $556.0M | 0.02% |